Loading clinical trials...
Loading clinical trials...
Exparel Versus Bupivacaine in Post-operative Pain Control Following Bilateral Third Molar Extractions: A Single-blind Randomized Clinical Trial
Conditions
Interventions
Bupivacaine liposome injectable suspension
Locations
1
United States
Case Western Reserve University
Cleveland, Ohio, United States
Start Date
August 21, 2024
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2025
Last Updated
April 13, 2026
NCT07432711
NCT04751344
Lead Sponsor
Case Western Reserve University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions